PT-141 vs Melanotan II
Comparison of FDA-approved PT-141 (Vyleesi) and unapproved Melanotan II - related peptides with different regulatory paths.
Last updated: January 19, 2026
PT-141
Melanotan II
Overview
PT-141 (bremelanotide) was derived from Melanotan II research but developed as a selective, FDA-approved medication. Melanotan II remains unapproved with significant safety concerns.
Regulatory Status
| Aspect | PT-141 | Melanotan II |
|---|---|---|
| FDA Status | Approved (2019) | Not approved |
| Brand Name | Vyleesi | None |
| Indication | HSDD in women | None |
| Warnings Issued | Standard labeling | Regulatory warnings |
Mechanism Comparison
| Aspect | PT-141 | Melanotan II |
|---|---|---|
| Receptor Selectivity | MC4R focused | Non-selective (MC1-5R) |
| Tanning Effect | Minimal at approved level | Significant |
| Sexual Effects | Primary indication | Side effect |
| Appetite Effects | Less | Present |
Safety Comparison
| Concern | PT-141 | Melanotan II |
|---|---|---|
| Nausea | Common (40%) | Common |
| Blood Pressure | Transient increase | Effects reported |
| Mole Changes | Not reported | Documented concern |
| Long-term Safety | Studied | Unknown |
| Product Quality | Pharmaceutical grade | Unregulated |
Clinical Evidence
| Aspect | PT-141 | Melanotan II |
|---|---|---|
| Phase 3 Trials | Yes (RECONNECT) | None |
| Efficacy Proven | Yes (HSDD) | No |
| Safety Established | Yes (short-term) | No |
Key Differences
PT-141 Advantages
- FDA approved with established safety
- Selective mechanism
- Pharmaceutical quality
- Proper clinical development
Melanotan II Concerns
- Regulatory warnings issued
- Non-selective effects
- Mole/pigmentation concerns
- Unregulated products
Why PT-141 Was Developed
PT-141 was specifically developed to:
- Isolate the sexual function effects
- Remove tanning/pigmentation activity
- Create an approvable medication
- Establish proper safety profile
Summary
| Factor | PT-141 | Melanotan II |
|---|---|---|
| Recommended | For approved indication | No |
| Safety Known | Yes | No |
| Quality Assured | Yes | No |
| Legal Status | Prescription | Illegal to sell |
This comparison is for educational purposes only. PT-141 requires a prescription. Melanotan II is not approved and has safety warnings.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.